{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-000616","form_type":"8-K","ticker":"CLRB","cik":"0001279704","company_name":"Cellectar Biosciences, Inc.","filed_at":"2023-01-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.205144+00:00","generated_at":"2026-06-20T20:11:30.527808+00:00","sec_items":["1.01","2.03"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Cellectar Biosciences amends NJ office lease through 2029, aggregate rent ~$918K","bullets":["Amended lease for 3,983 sq ft at 100 Campus Drive, Florham Park, NJ from March 1, 2023 to April 30, 2029.","Security deposit reduced from $75,000 to $23,566 under amended terms.","Aggregate rent approx. $918,000, reduced to ~$893,000 after rent abatements.","Company has option to extend term for one additional 60-month period."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-000616","json":"https://secwatch.observer/filing/0001104659-23-000616.json","markdown":"https://secwatch.observer/filing/0001104659-23-000616.md","text":"https://secwatch.observer/filing/0001104659-23-000616.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1279704/000110465923000616/0001104659-23-000616-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1279704/000110465923000616/tm231546d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T20:11:30.527808+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"688ad4e2155c886b1d957a73474b0d33652dd203","claim":"Cellectar Biosciences, Inc. amended lease obligation of approximately $918,000 with CAMPUS 100 LLC maturing April 30, 2029.","evidence_excerpt":"ntered into an Amended Agreement of Lease (the “Amended Lease”), with CAMPUS 100 LLC (the “Landlord”). Under the Amended Lease, the Company will continue to lease","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465923000616/0001104659-23-000616-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"lease obligation"},{"label":"Principal","value":"approximately $918,000"},{"label":"Counterparty","value":"CAMPUS 100 LLC"},{"label":"Maturity","value":"April 30, 2029"},{"label":"Event","value":"amendment"}],"fact_type":"debt_financing"},{"claim_id":"b6579f5e344b866fdc75549dcd1fee1199de7880","claim":"Cellectar Biosciences, Inc. amended Amended Agreement of Lease with CAMPUS 100 LLC (the \"Landlord\") valued at approximately $918,000 (effective 2022-12-30).","evidence_excerpt":"On December 30, 2022, Cellectar Biosciences, Inc. (the “Company”) entered into an Amended Agreement of Lease (the “Amended Lease”), with CAMPUS 100 LLC (the “Landlord”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465923000616/0001104659-23-000616-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"lease"},{"label":"Counterparty","value":"CAMPUS 100 LLC (the \"Landlord\")"},{"label":"Value","value":"approximately $918,000"},{"label":"Effective","value":"2022-12-30"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}